Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian...
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
About this item
Full title
Author / Creator
for the Japanese Gynecologic Oncology Group , Japanese Gynecologic Oncology Group , Katsumata, Noriyuki, Dr , Yasuda, Makoto, Prof , Takahashi, Fumiaki, PhD , Isonishi, Seiji, MD , Jobo, Toshiko, MD , Aoki, Daisuke, Prof , Tsuda, Hiroshi, MD , Sugiyama, Toru, Prof , Kodama, Shoji, MD , Kimura, Eizo, MD , Ochiai, Kazunori, Prof and Noda, Kiichiro, Prof
Publisher
Kidlington: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Paclitaxel and carboplatin given every 3 weeks is standard treatment for advanced ovarian carcinoma. Attempts to improve patient survival by including other drugs have yielded disappointing results. We compared a conventional regimen of paclitaxel and carboplatin with a dose-dense weekly regimen in women with advanced ovarian can...
Alternative Titles
Full title
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Japanese Gynecologic Oncology Group
Katsumata, Noriyuki, Dr
Yasuda, Makoto, Prof
Takahashi, Fumiaki, PhD
Isonishi, Seiji, MD
Jobo, Toshiko, MD
Aoki, Daisuke, Prof
Tsuda, Hiroshi, MD
Sugiyama, Toru, Prof
Kodama, Shoji, MD
Kimura, Eizo, MD
Ochiai, Kazunori, Prof
Noda, Kiichiro, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_21217592
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_21217592
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(09)61157-0
